The use of molecular markers in the diagnosis and treatment of colorectal cancer
- 31 December 2007
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Gastroenterology
- Vol. 21 (6), 1071-1087
- https://doi.org/10.1016/j.bpg.2007.10.002
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Adjuvant treatment of colorectal cancer.CA: A Cancer Journal for Clinicians, 2007
- The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen responseCritical Reviews in Oncology/Hematology, 2007
- Adjuvant therapy for colon cancerCurrent Oncology Reports, 2005
- Colorectal cancerThe Lancet, 2005
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerJournal of Clinical Oncology, 2004
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerThe New England Journal of Medicine, 2004
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- Cancer as a robust system: implications for anticancer therapyNature Reviews Cancer, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaThe New England Journal of Medicine, 1990